Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients

Background: Although Carbohydrate antigen 19-9 (CA19-9) is considered clinically useful and informative for pancreatic carcinoma (PC), false positive results, and false negative results have restricted its clinical use. Especially missed or delayed diagnosis of PC patients with negative CA19-9 value...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Front Oncol
Prif Awduron: Zhong, Ailing, Qin, Ruihuan, Qin, Wenjun, Han, Jing, Gu, Yong, Zhou, Lei, Zhang, Hongqin, Ren, Shifang, Lu, Renquan, Guo, Lin, Gu, Jianxin
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2019
Pynciau:
Oncology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6402387/
https://ncbi.nlm.nih.gov/pubmed/30873386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00114
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg